CN101193866B - 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)-苯胺的方法 - Google Patents

合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)-苯胺的方法 Download PDF

Info

Publication number
CN101193866B
CN101193866B CN2006800202295A CN200680020229A CN101193866B CN 101193866 B CN101193866 B CN 101193866B CN 2006800202295 A CN2006800202295 A CN 2006800202295A CN 200680020229 A CN200680020229 A CN 200680020229A CN 101193866 B CN101193866 B CN 101193866B
Authority
CN
China
Prior art keywords
imidazoles
trifluoromethyl
isophthalic acid
methyl isophthalic
aniline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800202295A
Other languages
English (en)
Chinese (zh)
Other versions
CN101193866A (zh
Inventor
M·阿克莫格鲁
B·申克尔
谢文忠
S·薛
E·威德默
P·加西亚芬特斯
J·马丁麦地纳
F·文森特巴诺斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN101193866A publication Critical patent/CN101193866A/zh
Application granted granted Critical
Publication of CN101193866B publication Critical patent/CN101193866B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN2006800202295A 2005-06-09 2006-06-07 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)-苯胺的方法 Expired - Fee Related CN101193866B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68892005P 2005-06-09 2005-06-09
US60/688,920 2005-06-09
PCT/US2006/022026 WO2006135619A1 (en) 2005-06-09 2006-06-07 Process for the synthesis of 5- (methyl- 1h-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine

Publications (2)

Publication Number Publication Date
CN101193866A CN101193866A (zh) 2008-06-04
CN101193866B true CN101193866B (zh) 2011-01-19

Family

ID=37085334

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800202295A Expired - Fee Related CN101193866B (zh) 2005-06-09 2006-06-07 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)-苯胺的方法

Country Status (20)

Country Link
US (1) US7709657B2 (https=)
EP (1) EP1896425B1 (https=)
JP (1) JP5139273B2 (https=)
KR (1) KR101319071B1 (https=)
CN (1) CN101193866B (https=)
AR (1) AR057351A1 (https=)
AT (1) ATE483690T1 (https=)
AU (1) AU2006258116B2 (https=)
BR (1) BRPI0611924A2 (https=)
CA (1) CA2610402C (https=)
DE (1) DE602006017369D1 (https=)
ES (1) ES2354115T3 (https=)
GT (1) GT200600207A (https=)
MX (1) MX2007015420A (https=)
PE (1) PE20070084A1 (https=)
PL (1) PL1896425T3 (https=)
PT (1) PT1896425E (https=)
RU (1) RU2404167C2 (https=)
TW (1) TW200710084A (https=)
WO (1) WO2006135619A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
GB0618832D0 (en) * 2006-09-25 2006-11-01 Phoenix Chemicals Ltd Chemical process
US20110053968A1 (en) * 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
EP3144194B1 (en) 2014-05-16 2018-05-09 Robert Bosch GmbH Abs hydraulic unit
KR102335216B1 (ko) 2017-04-26 2021-12-03 삼성전자 주식회사 발광소자 패키지
CN107235910B (zh) * 2017-07-31 2020-04-24 安礼特(上海)医药科技有限公司 一种尼洛胺的合成方法
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI831259B (zh) 2018-06-15 2024-02-01 漢達生技醫藥股份有限公司 包含達沙替尼十二烷基硫酸鹽組合物的膠囊
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005281A1 (en) * 2002-07-05 2004-01-15 Novartis Ag Inhibitors of tyrosine kinases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
PT672041E (pt) * 1993-10-01 2002-04-29 Novartis Ag Derivados da piridina farmacologicamente activos e processos para a sua preparacao
US6323366B1 (en) 1997-07-29 2001-11-27 Massachusetts Institute Of Technology Arylamine synthesis
US6395916B1 (en) 1998-07-10 2002-05-28 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
US7202367B2 (en) 2002-05-31 2007-04-10 Rhodia Chimie Process for arylating or vinylating or alkynating a nucleophilic compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005281A1 (en) * 2002-07-05 2004-01-15 Novartis Ag Inhibitors of tyrosine kinases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张洁,等.微波辅助含氮杂环的N - 芳基化反应.华西药学杂志19 4.2004,19(4),250-253.
张洁,等.微波辅助含氮杂环的N-芳基化反应.华西药学杂志19 4.2004,19(4),250-253. *

Also Published As

Publication number Publication date
ATE483690T1 (de) 2010-10-15
RU2007147927A (ru) 2009-07-20
CA2610402C (en) 2014-09-16
EP1896425B1 (en) 2010-10-06
RU2404167C2 (ru) 2010-11-20
BRPI0611924A2 (pt) 2010-10-05
JP5139273B2 (ja) 2013-02-06
MX2007015420A (es) 2008-02-21
EP1896425A1 (en) 2008-03-12
GT200600207A (es) 2007-01-15
DE602006017369D1 (de) 2010-11-18
CN101193866A (zh) 2008-06-04
PL1896425T3 (pl) 2011-04-29
KR20080016618A (ko) 2008-02-21
AU2006258116B2 (en) 2010-11-25
TW200710084A (en) 2007-03-16
US20080200691A1 (en) 2008-08-21
AR057351A1 (es) 2007-11-28
CA2610402A1 (en) 2006-12-21
WO2006135619A1 (en) 2006-12-21
AU2006258116A1 (en) 2006-12-21
KR101319071B1 (ko) 2013-10-17
JP2008545782A (ja) 2008-12-18
US7709657B2 (en) 2010-05-04
ES2354115T3 (es) 2011-03-10
PT1896425E (pt) 2010-11-30
PE20070084A1 (es) 2007-03-09

Similar Documents

Publication Publication Date Title
CN102174020B (zh) 合成有机化合物的方法
JP2008546645A5 (https=)
CN101193866B (zh) 合成5-(甲基-1h-咪唑-1-基)-3-(三氟甲基)-苯胺的方法
CN114573555B (zh) 一种用于治疗偏头痛的化合物的制备方法
CN116217495A (zh) 一种2-氨基嘧啶类化合物的制备方法
CN100528863C (zh) 舍吲哚的制备方法
CN1321118C (zh) 5-氮杂吲哚的制备方法
CN101638390A (zh) 6-甲基-3-氨基哒嗪的工业化制备方法
JP7082980B2 (ja) 6-アミノイソキノリンを調製する方法
TW202104164A (zh) 製造經取代之2-[2-(苯基)乙胺]烷醯胺衍生物之方法
CN104402860A (zh) 甲磺酸伊马替尼中间体的制备方法
CN121824498A (zh) 一种5-(1h-吡咯-1-基)-2-巯基苯并咪唑的合成方法
CN117865812A (zh) 一种合成2,4-二甲基-5-硝基氟苯的方法
HK40122859A (zh) 一种alk抑制剂化合物及其中间体的制备方法
HK40062068B (zh) 生产取代的2-[2-(苯基)乙基氨基]烷酰胺衍生物的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NOVARTIS CO., LTD.

Free format text: FORMER NAME: NOVARTIS AG

CP01 Change in the name or title of a patent holder

Address after: Basel, Switzerland

Patentee after: NOVARTIS AG

Address before: Basel, Switzerland

Patentee before: Novartis AG

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110119

CF01 Termination of patent right due to non-payment of annual fee